One common genetic change in anaplastic meningiomas is amplification of chromosome 17q23 containing the S6 kinase (S6K) gene. We show, for the first time to our knowledge, increased S6K mRNA expression in anaplastic meningiomas compared with benign tumors. To evaluate S6K as a candidate meningioma progression gene, we generated IOMM-Lee human meningioma cell lines overexpressing S6K. Whereas no effect of S6K overexpression on meningioma cell growth, motility, or adhesion was observed in vitro, S6K overexpression resulted in increased tumor size in vivo. Collectively, these results suggest that S6K is functionally important for meningioma progression and may represent a target for future meningioma therapy.

Original languageEnglish
Pages (from-to)295-298
Number of pages4
JournalAnnals of neurology
Issue number2
StatePublished - Aug 2004


Dive into the research topics of 'Functional significance of S6K overexpression in meningioma progression'. Together they form a unique fingerprint.

Cite this